Impact of Anxiety and Depression on the Level of Asthma Control Among Jordanian Adults with Asthma

IF 3.7 3区医学 Q2 ALLERGY

Journal of Asthma and Allergy Pub Date : 2024-05-19 DOI:10.2147/jaa.s457875

Ola Abu Al Karsaneh, Arwa Al Anber, Sofian Al Shboul, Moath Alrjoub, Omran Ibrahim Almashaqbeh, Mohammad Alqaisi, Rahaf Abuatieh, Suhaib Mohammad Ananzeh, Anas Mousa Hamad, Raneem Almomani, Mohammad Mahmoud Tommalieh

{"title":"Impact of Anxiety and Depression on the Level of Asthma Control Among Jordanian Adults with Asthma","authors":"Ola Abu Al Karsaneh, Arwa Al Anber, Sofian Al Shboul, Moath Alrjoub, Omran Ibrahim Almashaqbeh, Mohammad Alqaisi, Rahaf Abuatieh, Suhaib Mohammad Ananzeh, Anas Mousa Hamad, Raneem Almomani, Mohammad Mahmoud Tommalieh","doi":"10.2147/jaa.s457875","DOIUrl":null,"url":null,"abstract":"Purpose: Recent studies imply that psychological factors may actively contribute to the development of asthma. It is generally known that people with asthma frequently suffer from psychological illnesses. This association can make it challenging to reach asthma control. This study aimed to assess the prevalence of depression and anxiety among Jordanian adults with asthma, in addition to the link between asthma control levels and these psychological disorders. Patients and Methods: This cross-sectional study included 175 adults with asthma who visited the tertiary asthma clinic in three Jordanian Governmental hospitals. Sociodemographic data was collected directly from the patients who were assessed for their level of depression and anxiety using a self-administered questionnaire, the Hospital Anxiety and Depression Scale (HADS). Also, asthma control was assessed using the Asthma Control Test (ACT). The relation between the different sociodemographic variables and clinical data, particularly depression and anxiety and asthma control level, was assessed. Results: Among 175 asthmatic patients, 60.57% had poor disease control, 8% had anxiety alone, 11.43% had depression alone, and 53.14% had anxiety plus depression. Poor asthma control was significantly associated with anxiety and depression (p= 0.044) and low levels of education (p=0.001). Further, a lower level of education was also related to higher levels of anxiety and depression. Conclusion: Most of the assessed Jordanian patients with asthma had their disease poorly controlled. Anxiety and depression are common among the studied sample of adults with asthma, and they appear to affect the level of disease control, suggesting the possibility that addressing these psychological conditions could enhance asthma control levels. Keywords: Asthma, Asthma control, anxiety, depression, Jordan ","PeriodicalId":15079,"journal":{"name":"Journal of Asthma and Allergy","volume":"25 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Asthma and Allergy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/jaa.s457875","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Recent studies imply that psychological factors may actively contribute to the development of asthma. It is generally known that people with asthma frequently suffer from psychological illnesses. This association can make it challenging to reach asthma control. This study aimed to assess the prevalence of depression and anxiety among Jordanian adults with asthma, in addition to the link between asthma control levels and these psychological disorders.
Patients and Methods: This cross-sectional study included 175 adults with asthma who visited the tertiary asthma clinic in three Jordanian Governmental hospitals. Sociodemographic data was collected directly from the patients who were assessed for their level of depression and anxiety using a self-administered questionnaire, the Hospital Anxiety and Depression Scale (HADS). Also, asthma control was assessed using the Asthma Control Test (ACT). The relation between the different sociodemographic variables and clinical data, particularly depression and anxiety and asthma control level, was assessed.
Results: Among 175 asthmatic patients, 60.57% had poor disease control, 8% had anxiety alone, 11.43% had depression alone, and 53.14% had anxiety plus depression. Poor asthma control was significantly associated with anxiety and depression (p= 0.044) and low levels of education (p=0.001). Further, a lower level of education was also related to higher levels of anxiety and depression.
Conclusion: Most of the assessed Jordanian patients with asthma had their disease poorly controlled. Anxiety and depression are common among the studied sample of adults with asthma, and they appear to affect the level of disease control, suggesting the possibility that addressing these psychological conditions could enhance asthma control levels.

Keywords: Asthma, Asthma control, anxiety, depression, Jordan

查看原文本刊更多论文

焦虑和抑郁对约旦成人哮喘患者哮喘控制水平的影响

研究目的最近的研究表明，心理因素可能是导致哮喘发病的主要原因。众所周知，哮喘患者经常患有心理疾病。这种关联会使哮喘的控制面临挑战。本研究旨在评估约旦成年哮喘患者中抑郁和焦虑的患病率，以及哮喘控制水平与这些心理障碍之间的联系：这项横断面研究纳入了在约旦三家政府医院的三级哮喘门诊就诊的 175 名成人哮喘患者。研究人员直接收集了患者的社会人口学数据，并使用自制问卷--医院焦虑和抑郁量表（HADS）对患者的抑郁和焦虑程度进行了评估。此外，还使用哮喘控制测试（ACT）对哮喘控制情况进行了评估。评估了不同社会人口变量与临床数据之间的关系，尤其是抑郁、焦虑和哮喘控制水平：在 175 名哮喘患者中，60.57% 的患者病情控制不佳，8% 的患者仅有焦虑，11.43% 的患者仅有抑郁，53.14% 的患者焦虑加抑郁。哮喘控制不佳与焦虑和抑郁（p= 0.044）以及教育水平低（p=0.001）有明显关联。此外，教育水平低也与焦虑和抑郁程度较高有关：结论：大多数接受评估的约旦哮喘患者的病情控制不佳。焦虑和抑郁在所研究的成人哮喘样本中很常见，而且似乎会影响疾病控制水平，这表明解决这些心理问题有可能提高哮喘控制水平：哮喘哮喘控制焦虑抑郁约旦

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Asthma and Allergy Medicine-Immunology and Allergy

CiteScore

5.30

自引率

6.20%

发文量

185

审稿时长

16 weeks

期刊介绍： An international, peer-reviewed journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physiology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies. Although the main focus of the journal will be to publish research and clinical results in humans, preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies.